Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,996 INR | -0.09% | +2.48% | +16.39% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With an expected P/E ratio at 59.42 and 50.58 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.39% | 2.98B | B | ||
-18.17% | 8.55B | B+ | ||
+87.40% | 4.63B | C+ | ||
-3.15% | 2.65B | - | ||
-2.10% | 1.89B | C- | ||
-53.27% | 1.81B | B- | ||
-12.97% | 1.56B | A- | ||
+21.59% | 1.27B | B+ | ||
-47.96% | 1.07B | C+ | ||
-4.64% | 997M | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LALPATHLAB Stock
- LALPATHLAB Stock
- Ratings Dr. Lal PathLabs Limited